Shopping Cart

Your shopping cart is currently empty

Meticrane

Name: Meticrane
Brand: TargetMol
SKU: T0275
Price: 33 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T0275Cas No. 1084-65-7

Alias Fontiliz, Arresten

Meticrane (Arresten) is a sulphonamide-derivative with thiazide-like diuretic activity.

Meticrane

Copy Product Info

😃Good

Purity: 99.16%

Catalog No. T0275Alias Fontiliz, ArrestenCas No. 1084-65-7

Meticrane (Arresten) is a sulphonamide-derivative with thiazide-like diuretic activity.

Pack Size	Price	USA Warehouse	Global Warehouse
50 mg	$33	In Stock	In Stock
100 mg	$47	In Stock	In Stock
200 mg	$68	In Stock	In Stock
500 mg	$112	-	In Stock
1 mL x 10 mM (in DMSO)	$52	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.16%

Appearance:Solid

Color:White

Resource Download

COA LCMS HNMR

Product Introduction

Meticrane AI Summary

Meticrane exhibits a range of bioactivities including moderate potency in modulating Lamin A splicing (707.9 nM) and relatively high potency as an inhibitor or substrate of Cytochrome P450 2C9 (12589.3 nM). It has weaker potency in inhibiting HP1-beta Chromodomain interactions with methylated histone tails (100000.0 nM) and demonstrates moderate potency in the Schwann cell PMP22 intronic element luciferase assay (3886.4 nM). It induces DNA re-replication in normal breast cells (20596.2 nM) and acts as an antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2) with a potency of 63095.7 nM. The compound also shows activity in blocking Ebola virus entry with AC50 values ranging from 3.162 to 5011.9 uM in different assays. Regarding antiviral activity, Meticrane was tested against SARS-CoV-2 in various assays. It shows inhibition of SARS-CoV-2 induced cytotoxicity in Caco-2 cells at 10 uM after 48 hours (-7.21%) and in VERO-6 cells at 10 uM concentration, with an IC50 value greater than 20000.0 nM. It also demonstrated a hit score of 0.2902 in HRCE cells against the SARS-CoV-2 (USA-WA1/2020 strain). However, in Vero E6 cells, it did not exhibit inhibitory activity against SARS-CoV-2 (negative inhibition index of -0.03039). Additionally, it inhibits the SARS-CoV-2 3CL-Pro protease by 13.35% at 20µM using a FRET-based assay. Furthermore, Meticrane shows inhibitory activity on human HDAC6 with inhibition percentages of 7.25% using a commercial peptide substrate and -7.26% with a custom peptide substrate, suggesting a possible differential effect based on substrate type. Despite these activities, the compound demonstrated limited bioactivity against a broad spectrum of targets, including dopamine and adrenergic receptors, among others, with no significant binding affinities or inhibitory effects observed. Overall, Meticrane has a diverse bioactivity profile but shows limited strong bioactivity against the broad range of tested targets..

Note: Summary generated by AI. Data source: ChEMBL

Bioactivity

Description	Meticrane (Arresten) is a sulphonamide-derivative with thiazide-like diuretic activity.
Synonyms	Fontiliz, Arresten

Chemical Properties

Molecular Weight	275.34
Formula	C₁₀H₁₃NO₄S₂
Cas No.	1084-65-7
Smiles	Cc1cc2CCCS(=O)(=O)c2cc1S(N)(=O)=O
Relative Density.	1.464g/cm3

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 60 mg/mL (217.91 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.26 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.6319 mL	18.1594 mL	36.3187 mL	181.5937 mL
5 mM	0.7264 mL	3.6319 mL	7.2637 mL	36.3187 mL
10 mM	0.3632 mL	1.8159 mL	3.6319 mL	18.1594 mL
20 mM	0.1816 mL	0.9080 mL	1.8159 mL	9.0797 mL
50 mM	0.0726 mL	0.3632 mL	0.7264 mL	3.6319 mL
100 mM	0.0363 mL	0.1816 mL	0.3632 mL	1.8159 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc